Float Short %

2.55

Margin Of Safety %

-6

Put/Call OI Ratio

0.81

EPS Next Q Diff

0.03

EPS Last/This Y

EPS This/Next Y

0.45

Price

88.76

Target Price

103.09

Analyst Recom

1.46

Performance Q

16.4

Relative Volume

1.06

Beta

1.29

Ticker: DXCM

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-01-23	DXCM	87.7	0.81	1.24	106105
2025-01-24	DXCM	88.75	0.82	0.83	108231
2025-01-27	DXCM	87.41	0.81	0.75	106109
2025-01-28	DXCM	88.33	0.82	0.79	108098
2025-01-29	DXCM	86.43	0.82	0.96	109104
2025-01-30	DXCM	87.58	0.84	0.74	110033
2025-01-31	DXCM	86.84	0.84	0.98	112553
2025-02-03	DXCM	87.04	0.86	0.35	110218
2025-02-04	DXCM	87.43	0.85	0.53	111345
2025-02-05	DXCM	88.75	0.85	1.05	112559
2025-02-06	DXCM	88.31	0.86	0.62	114279
2025-02-07	DXCM	87.97	0.86	0.41	114951
2025-02-10	DXCM	88.25	0.87	1.26	110054
2025-02-11	DXCM	86.39	0.89	0.80	112388
2025-02-12	DXCM	83.87	0.90	0.31	113441
2025-02-13	DXCM	84.05	0.88	1.22	116835
2025-02-14	DXCM	89.04	0.89	0.88	128316
2025-02-18	DXCM	90.53	0.86	0.26	116928
2025-02-19	DXCM	89.69	0.83	0.07	120989
2025-02-20	DXCM	89.37	0.81	0.27	123598
2025-02-21	DXCM	88.79	0.81	0.30	123857
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-01-23	DXCM	87.70	0.1	65.7	1.71
2025-01-24	DXCM	88.78	0.1	70.1	1.71
2025-01-27	DXCM	87.49	0.1	48.3	1.71
2025-01-28	DXCM	88.37	0.1	67.9	1.71
2025-01-29	DXCM	86.46	0.1	42.4	1.71
2025-01-30	DXCM	87.62	0.1	71.3	1.71
2025-01-31	DXCM	86.80	0.1	52.3	1.71
2025-02-03	DXCM	87.05	0.1	62.1	1.71
2025-02-04	DXCM	87.42	0.1	63.5	1.71
2025-02-05	DXCM	88.83	0.1	72.1	1.71
2025-02-06	DXCM	88.33	0.1	55.8	1.71
2025-02-07	DXCM	88.09	0.1	57.9	1.71
2025-02-10	DXCM	88.27	0.1	61.8	1.71
2025-02-11	DXCM	86.37	0.1	42.3	1.71
2025-02-12	DXCM	83.87	0.1	36.1	1.71
2025-02-13	DXCM	84.09	0.1	62.1	1.71
2025-02-14	DXCM	89.07	0.1	112.6	1.71
2025-02-18	DXCM	90.56	1.8	73.8	2.03
2025-02-19	DXCM	89.68	2.2	38.3	2.02
2025-02-20	DXCM	89.37	2.2	78.0	2.02
2025-02-21	DXCM	88.76	2.2	75.6	2.02
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-01-23	DXCM	-0.30	-2.50	2.28
2025-01-24	DXCM	-0.30	-2.50	2.28
2025-01-27	DXCM	-0.30	-2.50	2.28
2025-01-28	DXCM	-0.30	-2.50	2.28
2025-01-29	DXCM	-0.30	-2.50	2.28
2025-01-30	DXCM	-0.30	-2.50	2.28
2025-01-31	DXCM	-1.11	-2.50	2.28
2025-02-03	DXCM	-1.10	-3.50	2.28
2025-02-04	DXCM	-1.10	-3.50	2.28
2025-02-05	DXCM	-1.09	-3.50	2.28
2025-02-06	DXCM	-1.09	-3.50	2.28
2025-02-07	DXCM	-1.09	-3.50	2.28
2025-02-10	DXCM	-1.09	-2.80	2.28
2025-02-11	DXCM	-0.71	-2.80	2.30
2025-02-12	DXCM	-0.71	-2.80	2.57
2025-02-13	DXCM	-1.09	-2.80	2.55
2025-02-14	DXCM	-1.09	-2.80	2.55
2025-02-18	DXCM	-1.08	-2.15	2.55
2025-02-19	DXCM	-1.01	-2.15	2.56
2025-02-20	DXCM	-1.03	-2.15	2.56
2025-02-21	DXCM	-1.03	-2.15	2.55
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.45

Avg. EPS Est. Current Quarter

0.33

Avg. EPS Est. Next Quarter

0.48

Insider Transactions

-1.03

Institutional Transactions

-2.15

Beta

1.29

Average Sales Estimate Current Quarter

1017

Average Sales Estimate Next Quarter

1129

Fair Value

82.99

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

46.2

Max Drawdown 5-Year %

-60.7

Target Price

103.09

P/E

62.32

Forward P/E

35.85

PEG

2.76

P/S

8.6

P/B

16.5

P/Free Cash Flow

55.01

EPS

1.42

Average EPS Est. Cur. Y

2.02

EPS Next Y. (Est.)

2.47

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

14.29

Relative Volume

1.06

Return on Equity vs Sector %

8.2

Return on Equity vs Industry %

15.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

75.6

DexCom, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 10200

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

stock quote shares DXCM – DexCom, Inc. Stock Price stock today

news today DXCM – DexCom, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch DXCM – DexCom, Inc. yahoo finance google finance

stock history DXCM – DexCom, Inc. invest stock market

stock prices DXCM premarket after hours

ticker DXCM fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: DXCM

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y